ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-OR10

Crystalluria Impairs Macrophage Function During Kidney Stone Formation

Session Information

Category: Bone and Mineral Metabolism

  • 402 Bone and Mineral Metabolism: Clinical

Authors

  • Mitchell, Tanecia, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Laurence, Emma, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Kumar, Parveen, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
Background

Approximately 10% of the United States population will form a kidney stone in their lifetime. Increased consumption of oxalate-rich meals is positively associated with urinary oxalate levels and stone formation. Macrophages are essential for removing crystals, which are the precursors to kidney stones, and rely on mitochondria and lysosomes to carry out their function. Interleukin-10 (IL-10) is an anti-inflammatory cytokine that regulates mitochondrial function in macrophages. The purpose of this study was to determine whether urinary nanocrystals reduce macrophage metabolism, signaling, and mitochondrial/lysosomal function. We hypothesize human urinary nanocrystals impair macrophage metabolism, IL-10 signaling, and mitochondrial quality control.

Methods

Ten adult healthy subjects and CaOx stone formers consumed controlled high oxalate diets for 4 days. Urine was collected 24 hours before and after the dietary regimen. Urinary nanocrystals were characterized using nanoparticle tracking analysis and subsequently exposed to macrophages (human and THP-1 monocyte-derived macrophages) with or without exogenous IL-10 (40 ng/ml) for 24 hours. Cell viability was measured using the MTT assay and metabolism was assessed using the Seahorse XF Analyzer. Mitochondrial and lysosomal gene expression and protein levels were determined using real-time quantitative reverse transcription-PCR, western blotting, or confocal microscopy. Mitochondrial reactive oxygen species (ROS) levels, mitochondrial membrane potential, and lysosomal activity were assessed using fluorescent-based plate reader assays.

Results

Our results show that high oxalate diets stimulate urinary nanocrystals and these crystals impair macrophage viability, metabolism, IL-10 and ROS signaling, mitochondrial and lysosomal gene expression and protein levels, and mitochondrial quality control. Further, we determined that exogenous IL-10 treatment prevented these outcomes.

Conclusion

These findings suggest that urinary nanocrystals impact macrophage function and this may reduce their ability to prevent kidney stone formation and growth. Future studies will determine mechanisms contributing to IL-10 signaling impairment in macrophages following oxalate exposure and test potential therapies to improve macrophage function during kidney stone formation.

Funding

  • NIDDK Support